Global Neurology Academy
The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.
For more information about GNA, visit www.globalneurologyacademy.org.
196-210 of 233
Reviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
NeuroFrontiersReviewing the Revised Alzheimer’s Diagnostic Criteria: The Role of Biomarkers
Clifford Jack Jr., MD
5 Things You Need to Know About Epilepsy & Depression
CME/CE5 Things You Need to Know About Epilepsy & Depression
Heidi M. Munger Clary, MD, MPH
Jay Salpekar, MD, FANPA
Mind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS
NeuroFrontiersMind Matters: Psychiatric Comorbidity in the Prodromal Phase of MS
Charles Turck, PharmD, BCPS, BCCCP
Anibal Chertcoff, MD
Diagnosing Suspected MS: A Review of the Updated Guidelines
NeuroFrontiersDiagnosing Suspected MS: A Review of the Updated Guidelines
Andrew Wilner, MD, FACP, FAAN
Eoin Flanagan, MB, BCh
Advances in Temporal Lobe Epilepsy Research
NeuroFrontiersAdvances in Temporal Lobe Epilepsy Research
Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
Sanjay Kumar, PhD
Jerome Lisk, MD, MBA, M.S., FAAN
Mark Mintz, MD
- advertisement
Investigating the Link Between Hypertension Medications & Dementia
NeuroFrontiersInvestigating the Link Between Hypertension Medications & Dementia
Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
Zachary Marcum, PharmD, PhD
B-Cell Therapy: When Is It Right for Our MS Patients?
NeuroFrontiersB-Cell Therapy: When Is It Right for Our MS Patients?
Charles Turck, PharmD, BCPS, BCCCP
Andrew Chan, MD
Alzheimer’s Disease: What’s The Latest Research?
NeuroFrontiersAlzheimer’s Disease: What’s The Latest Research?
Jerome Lisk, MD, MBA, M.S., FAAN
Peter Whitehouse, MD, PhD
Daniel George, MSc, PhD
Diving into the Debate Surrounding Aducanumab for Alzheimer’s
NeuroFrontiersDiving into the Debate Surrounding Aducanumab for Alzheimer’s
Jerome Lisk, MD, MBA, M.S., FAAN
Peter Whitehouse, MD, PhD
Investigating the Impact of Mobile Stroke Units
NeuroFrontiersInvestigating the Impact of Mobile Stroke Units
Investigating the Potential Link Between Epstein-Barr Virus & MS
NeuroFrontiersInvestigating the Potential Link Between Epstein-Barr Virus & MS
- advertisement
Keys to Closing the Gender Gap in Stroke Trials
NeuroFrontiersKeys to Closing the Gender Gap in Stroke Trials
Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
Cheryl Carcel, MD, PhD
Diagnosing Mental Illness with the Perspectives Approach
NeuroFrontiersDiagnosing Mental Illness with the Perspectives Approach
Charles Turck, PharmD, BCPS, BCCCP
Margaret Chisolm, MD
Jerome Lisk, MD, MBA, M.S., FAAN
Shivashankar Othy, DVM, PhD
